The pharmaceutical company Alphapharm has notified us about a shortage of fluoxetine 20 mg dispersible tablets (Zactin Tabs) due to manufacturing issues. The shortage is expected to continue until 29 February 2024.
Fluoxetine is an antidepressant used to treat major depression, obsessive-compulsive disorder (OCD) and premenstrual dysphoric disorder.
Patients should continue to take their Zactin Tabs as usual and see their doctor or pharmacist to be switched to a fluoxetine capsule or other suitable alternative. Multiple brands of fluoxetine capsule products are still available.
